<DOC>
	<DOCNO>NCT02499445</DOCNO>
	<brief_summary>In patient undergo off-pump coronary artery bypass ( OPCAB ) surgery different anesthesia regimen : remifentanil ( 0.75 mcg/kg/min ) propofol ( TCI effect-site concentration 0.8-1.5 mcg/ml ) ( Group -RP ) ; remifentanil ( 0.75 mcg/kg/min ) sevoflurane ( end-tidal 0.8 vol % ) ( Group-RS ) , sevoflurane ( end-tidal 1.2-2.8 vol % ) -sufentanil ( TCI effect site concentration 0.35-0.75 ng/ml ) ( Group-SS ) , intergroup difference level Troponin I ( c-TnI ) creatinine kinase subtype-MB determine surgery ( control ) , vascular graft harvesting ( harvest ) , complete graft construction ( postgrafting ) , one day surgery ( postoperative ) .</brief_summary>
	<brief_title>Myocardial Injury Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens OPCAB Surgery</brief_title>
	<detailed_description>To determine difference myocardial injury upon use different anesthesia regimen : remifentanil-based regimen versus sevoflurane-sufentanil balanced regimen . Patients undergo off-pump coronary artery bypass ( OPCAB ) surgery randomly allocate get remifentanil ( 0.75 mcg/kg/min ) propofol ( TCI effect-site concentration 0.8-1.5 mcg/ml ) ( Group -RP ) , remifentanil ( 0.75 mcg/kg/min ) sevoflurane ( end-tidal 0.8 vol % ) ( Group-RS ) , sevoflurane ( end-tidal 1.2-2.8 vol % ) -sufentanil ( TCI effect site concentration0.35-0.75 ng/ml ) ( Group-SS ) . Intergroup difference level Troponin I ( c-TnI ) creatine kinase-MB determine surgery ( control ) , vascular graft harvesting ( harvest ) , complete graft construction ( postgrafting ) , 1 day surgery ( postoperative ) .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>patient undergo OPCAB surgery patient sign write informed consent patient Intraaortic balloon pump patient renal replacement therapy patient want withdraw participation study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>